share_log

CohBar Has Received A Notice Of Allowance For Its U.S. Patent Application Titled "THERAPEUTIC PEPTIDES (FOR THE TREATMENT OF METABOLIC DISEASE, CANCER, LIVER DISEASE, AND METHODS OF MODULATING FATTY ACID METABOLISM)"

CohBar Has Received A Notice Of Allowance For Its U.S. Patent Application Titled "THERAPEUTIC PEPTIDES (FOR THE TREATMENT OF METABOLIC DISEASE, CANCER, LIVER DISEASE, AND METHODS OF MODULATING FATTY ACID METABOLISM)"

CohBar 已收到允許其名爲 “治療肽(用於治療代謝性疾病、癌症、肝臟疾病和調節脂肪酸代謝的方法)” 的美國專利申請的批准通知
Benzinga ·  2023/07/19 13:58

CohBar Has Received A Notice Of Allowance For Its U.S. Patent Application Titled "THERAPEUTIC PEPTIDES (FOR THE TREATMENT OF METABOLIC DISEASE, CANCER, LIVER DISEASE, AND METHODS OF MODULATING FATTY ACID METABOLISM)"

CohBar 已收到允許其名爲 “治療肽(用於治療代謝性疾病、癌症、肝臟疾病和調節脂肪酸代謝的方法)” 的美國專利申請的批准通知

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論